Commercial law firm Heuking Kühn Lüer Wojtek provided counsel to BioScience Ventures Group AG during another financing round. At the beginning of August 2010, a financing round for EUR 3 million was successfully concluded at Apeptico Forschung und Entwicklung GmbH.
In addition to BioScience Ventures Group AG, investors and business angels from Germany and Switzerland participated.
BioScience Ventures Group is a group of business angels specializing exclusively in investments in early stages of biotechnology.
Apeptico Forschung is a biotechnology company developing new drugs based on peptides.
Counsel to The BioScience Ventures Group AG: Heuking Kühn Lüer Wojtek, Munich: Dr. Mathias Schröder, LLM (Lead), Dr. Frank Metz